Cann Global Limited

ASX:CGB ISIN:AU0000038085

Cann Global Limited ASX:CGBCann Global Limited's (ASX:CGB) primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets.

Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group.

The Group also retains an interest in its existing Bauxite Projects.



Cann Global Limited (ASX:CGB) Quarterly Activities and Cashflow Report

🕔8/3/2020 8:06:52 AM 35348

Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales.

Read Full Article

Cann Global Limited (ASX:CGB) Entitlement Issue Update and Shortfall Notification

🕔7/28/2020 7:14:24 PM 36139

Cann Global Limited (ASX:CGB) is pleased to confirm that the 1 for 4 renounceable entitlement offer announced on 3 July 2020 (Entitlement Offer), closed on Thursday 23 July 2020.

Read Full Article

Cann Global Limited (ASX:CGB) Rights Issue Update

🕔7/10/2020 4:52:02 PM 34033

Cann Global Ltd (ASX:CGB) today confirms that its Directors and largest shareholders intend to participate in the rights issues announced on 3 July 2020.

Read Full Article

Cann Global Limited (ASX:CGB) Research Results Lead to Broader Auto-immune Research

🕔6/15/2020 10:11:11 AM 34624

Cann Global Limited's (ASX:CGB) medical Cannabis research division, Medical Cannabis Research Group Pty Ltd (MCRG) entered into a research agreement to research the possibility of the use of cannabis in the treatment of autoimmune disease, specifically multiple sclerosis (MS).

Read Full Article

Cann Global Limited (ASX:CGB) Cann Global Asia Update

🕔6/15/2020 9:36:50 AM 33791

The Board of Cann Global Limited (ASX:CGB) wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR.

Read Full Article

Cann Global Limited (ASX:CGB) Replacement March 2020 Quarterly Activities Report

🕔5/5/2020 8:28:45 AM 24556

On 30 April 2020, Cann Global Ltd (ASX:CGB) lodged the Company's quarterly activities and cashflow reports for the period ended 31 March 2020. This amendment includes an updated cashflow report.

Read Full Article

Cann Global Limited (ASX:CGB) Quarterly Activities Report

🕔5/1/2020 8:14:25 AM 15132

In October 2019, Austrade published a report on Australia's food innovators which Cann Global Limited (ASX:CGB), through its subsidiaries T12 and HHC, is very excited to be a part of.

Read Full Article

Cann Global Limited (ASX:CGB) Refinancing Extension of Notes and Re-investment

🕔3/19/2020 2:25:25 PM 13830

Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has entered into agreements for the refinancing of the convertible notes currently on issue through an assignment and variation arrangement.

Read Full Article

Cann Global Limited (ASX:CGB) Half Yearly Report and Accounts

🕔3/2/2020 8:19:49 AM 6773

The Directors present their report together with the financial statements, on the consolidated entity (referred to hereafter as 'the Group'), consisting of Cann Global Limited ('the Company') and the entities it controlled at the end of or during the half-year ended 31 December 2019.

Read Full Article

Cann Global Limited (ASX:CGB) Share Placement

🕔2/17/2020 9:58:39 AM 5259

Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has agreed to place 34 million new fully paid ordinary shares (New Shares) to institutional and sophisticated investors led by New York-based Sea Otter Global.

Read Full Article


  • This Page Viewed: (Last 7 Days: 140) (Last 30 Days: 566) (Since Published: 44900) 

Company Data

  • Level 21, 133 Castlereagh Street
    Sydney NSW 2023
  • Telephone
  • +61-2-8379-1832 
  • Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • E:

Company Reports

More News Results

  • 2024/03/01: Removal from Official List*
  • 2024/02/28: Company Update*
*refer to company website

Latest Videos

Quarterly Report

Download Presentation

Social Media